ATXN3 and cervical carcinoma: As JAK3 is a well-established upstream kinase of STAT5 [39, 40] and has been reported to play a critical role in cervical cancer progression [35–38, 41, 42], we modeled ATXN3’s interaction with phosphorylated JAK3 (p-JAK3, Y980).